Related Experiment Videos
Management of chronic viral hepatitis in children
H S Conjeevaram1, A M Di Bisceglie
1Liver Diseases Section, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Insights
Chronic viral hepatitis in children causes serious health issues and long-term complications like cirrhosis. Early recognition and prevention are crucial, especially in endemic areas, while alpha interferon shows promise for hepatitis B.
Area of Science:
- Pediatric infectious diseases
- Hepatology
- Viral gastroenterology
Background:
- Chronic viral hepatitis affects children globally, leading to significant illness and death.
- Early childhood infection increases risks for long-term problems such as cirrhosis and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To highlight the prevalence and risks of chronic viral hepatitis in pediatric populations.
- To emphasize the need for recognition, control, and prevention strategies.
- To review the potential role of alpha interferon therapy.
Main Methods:
- Literature review on pediatric chronic viral hepatitis.
- Analysis of disease progression and complications.
- Evaluation of therapeutic interventions like alpha interferon.
Main Results:
- Alpha interferon therapy can accelerate disease remission in some chronic hepatitis B cases.
- Further research is required to establish interferon's efficacy for chronic hepatitis D (HDV) and hepatitis C (HCV) in children.
Conclusions:
- Chronic viral hepatitis in children poses a substantial public health challenge requiring focused prevention and management.
- Targeted interventions and continued research are essential to combat pediatric viral hepatitis.
Abstract:
Chronic viral hepatitis is prevalent worldwide in the pediatric population and can be associated with significant morbidity and mortality. Acquisition of disease in early childhood may predispose children to long-term complications, including cirrhosis and HCC. Efforts should be made to recognize, control, and prevent further spread of these infections, especially in areas where hepatitis is endemic. Alpha interferon therapy hastens disease remission in a proportion of patients with chronic hepatitis B. Further studies are needed to define the role of interferon in chronic HDV and HCV infection in children.